公司資料
MediciNova 股價、新聞與催化劑
- 股票代碼:
- MNOV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.45 USD (+36.90%)
收盤價
最後更新: 2026年9月17日
66M USD
市值
股價為何變動
截至 2026年9月17日，MNOV 上漲 36.9%，收於 $3.45。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
MediciNova is a biotechnology company with programs in inflammation, fibrosis, and neurological disease. Its story is built around repurposing and selective development rather than broad commercial scale.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, MediciNova sits in specialty biotechnology.
商業模式特徵
The company depends on clinical data, pipeline prioritization, and the chance to build value from a narrow set of programs.
生技產業定位
MediciNova is a small-cap biotech name whose valuation depends on a few clinical catalysts.
未來催化劑
- MediciNova’s catalysts are its repurposed pipeline assets and any strategic update that clarifies which programs still matter. The company needs a clearer clinical path to regain attention.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。